One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1136/rmdopen-2019-001005
Copy DOI Journal: RMD Open |  Publication Date: Sep 1, 2019 |
 Citations: 68 |  License type: open-access |
Affiliation: Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Oregon Health & Science University, Tris Pharma (United States), Novartis (United States), Ghent University Hospital, VIB-UGent Center for Inflammation Research, Ghent University, Altoona Arthritis and Osteoporosis Center, Altoona Center for Clinical Research, Barts Health NHS Trust, Charité - Universitätsmedizin BerlinObjectiveThis study aimed to report end-of-study results on efficacy and safety of secukinumab 150 mg through 5 years in patients with ankylosing spondylitis (AS; MEASURE 1 extension trial (NCT01863732)).MethodsAfter the...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
